-
Core CAR-T products achieved sales of $500 million last year, and Legendary Biotech received a merger offer
On July 12th, according to the financial news website Street Insider, Legendary Biotech (LEGN. NASDAQ) received a merger offer and hired investment bank Centerview Partners to review and evaluate the ...